In molecular apocrine tumors, in addition to the classical androgen-induced signaling transduction, an overexpression of HER2 associates with AR positivity that suggests a cross-talk between the AR and HER2 signaling pathways [52]. This evidence concerns the gene AR and apocrine sweat gland neoplasm.